Bio-Pharm News Archives - Catalyst picR

skip to content

Anavex Life Sciences Withdraws EU Marketing Application for Blarcamesine

NewsDesk - March 25, 2026 9:55 am

Aldeyra Therapeutics ($ALDX) Receives FDA Complete Response Letter for Reproxalap

NewsDesk - March 17, 2026 8:52 am

Nasus Pharma ($NSRX) Reports Positive Phase 2 Results for NS002 Intranasal Epinephrine

Staff Writer - March 16, 2026 8:04 am

CATALYST News

M&T Bank ($MTB) Q1 Revenue Slightly Above Estimates; EPS Up YoY

Catalyst Desk - April 15, 2026 6:16 am

Citigroup ($C) Q1 Revenue and EPS Above Estimates; Deposit Increase

NewsDesk - April 14, 2026 8:40 am

Albertsons ($ACI) Q4 Earnings Top Estimates; Revenue Falls Short, Guides FY26

Staff Writer - April 14, 2026 8:16 am

Creative Realities ($CREX) Q4 EPS Misses; Revenue Beats Estimates

NewsDesk - April 14, 2026 8:00 am

CarMax ($KMX) Q4 EPS Beats Estimates; Revenue Declines

Staff Writer - April 14, 2026 7:43 am

JPMorgan Chase ($JPM) Q1 EPS Beats, Revenue Exceeds; Markets Revenue Up 20% YoY

Catalyst Desk - April 14, 2026 7:35 am

Wells Fargo ($WFC) Q1 EPS Misses; Revenue Up YoY

NewsDesk - April 14, 2026 7:31 am

Johnson & Johnson ($JNJ) Q1 EPS Beats, Revenue Surpasses; FY26 Outlook Raised

Staff Writer - April 14, 2026 7:00 am

BlackRock ($BLK) Q1 EPS and Revenue Beat Estimates; Revenue Up 27% YoY

NewsDesk - April 14, 2026 6:49 am

Unity Bancorp ($UNTY) Q1: Revenue and EPS Exceed Projections; YoY Gains

Staff Writer - April 14, 2026 6:45 am